ÌÇÐÄÆƽâ°æ

Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2024

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2025

Region

China

Survey time period

2024

Citation formats

Therapeutic areas for approved biopharmaceutical NDA in China 2024

Published by A. Minhas, Jun 26, 2025

In 2024, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved *** New Drug Applications (NDA) for biopharmaceuticals. more than ** percent of all approvals were granted to antineoplastic drugs, while biopharmaceuticals for the treatment of blood system and endocrine system diseases were also prevalent among the approvals.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Cancer in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cancer in China

Cancer prevalence

6

Cancer deaths

5

Treatment demands

7

Specialist hospitals and oncology wards

5

Cancer medications

7

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.